The Deal Register
Database › Equity financing › ZYUS Life Sciences Provides an Update on Its Unit Offering

Equity financing

ZYUS Life Sciences Provides an Update on Its Unit Offering

Lane
Equity financing
Announced
10 Apr 2026
Province
Saskatchewan
Industry
Healthcare & life sciences
Status
Announced
What the filing says
ZYUS Life Sciences Corporation (the " Company ") (TSXV: ZYUS ), a clinical stage life sciences company focused on the development and commercialization of novel non-opioid pharmaceutical drug candidates for pain management provides an update on its previously announced non-brokered private placement (the " Offering ").
Terms stated
price per security
Releases (2)
  • 20 Mar 2026 — ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering
  • 10 Apr 2026 — ZYUS Life Sciences Provides an Update on Its Unit Offering
Source

The terms are in the subscriber edition

This transaction carries 1 stated term, with its value, unit and basis and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe